Related Experiment Videos
[Clinical research of compound salviae miltiorrhizae injection for severe pancreatitis]
Abstract:
Compound salviae miltiorrhizae injection was administered after operation for 28 cases of severe pancreatitis, and 13 cases were taken as a control group. The results showed that: (1) the difference was not obvious in the morbidity of complications between the two groups, but the mortality (3.6%) of the trial group was significantly lower than that (30.8%) of the control group (P < 0.05); (2) Hematocrit was clearly decreased from 46.1 +/- 5.2% to 33.2 +/- 3.9% in the trial one (P < 0.05), but platelet and hemoglobin showed no statistical significance. It is concluded that compound salviae miltiorrhiza injection might improve hemorheologic abnormalities of the disease, promote the recovery of the pancreatic tissue, and correct the serious complications such as adult respiratory distress syndrome etc.
Insights
Compound salviae miltiorrhizae injection significantly reduced mortality in severe pancreatitis patients. While complications were similar, this treatment improved hemorheologic abnormalities and pancreatic tissue recovery.
Area of Science:
- Pharmacology
- Gastroenterology
- Critical Care Medicine
Background:
- Severe pancreatitis is a life-threatening condition with high mortality rates.
- Hemorheologic abnormalities and pancreatic tissue damage are key pathological features.
- Effective treatments for severe pancreatitis remain a critical medical challenge.
Purpose of the Study:
- To evaluate the efficacy of compound salviae miltiorrhizae injection in treating severe pancreatitis.
- To assess the impact of the injection on patient mortality, complication rates, and hematologic parameters.
- To investigate the potential of this treatment in improving hemorheologic abnormalities and promoting pancreatic tissue recovery.
Main Methods:
- A prospective study involving 28 patients with severe pancreatitis treated with compound salviae miltiorrhizae injection.
- A control group of 13 patients with severe pancreatitis received standard care.
- Comparison of mortality, complication morbidity, hematocrit, platelet count, and hemoglobin levels between the groups.
Main Results:
- Mortality was significantly lower in the treatment group (3.6%) compared to the control group (30.8%) (P < 0.05).
- Hematocrit levels significantly decreased in the treatment group (from 46.1 +/- 5.2% to 33.2 +/- 3.9%) (P < 0.05).
- No significant differences were observed in complication morbidity, platelet count, or hemoglobin levels between the groups.
Conclusions:
- Compound salviae miltiorrhizae injection demonstrates a significant survival benefit in severe pancreatitis.
- The treatment may improve hemorheologic abnormalities, evidenced by hematocrit changes.
- Further research is warranted to elucidate the mechanisms of action and broader clinical applications.